Background: Primary small-cell neuroendocrine carcinoma of the esophagus is a rare and aggressive malignancy, accounting for less than 3% of esophageal cancers. Its biological behavior resembles that of small-cell lung cancer, with rapid growth, early lymphatic spread, and a poor prognosis. No standardized treatment ex...
S. Ichou, I. Hassnaoui, A. Lachgar et al.· MedPeer publisher· 0 citations
This study evaluates the clinical outcomes, treatment patterns, and safety of brain SRT for limited brain metastases (BM) in a Moroccan tertiary oncology center, addressing the scarcity of North African real-world data. We retrospectively analyzed patients with brain metastases treated with SRT (2022–2025), assessing s...
A. Majdi, B. Agdi, F. Chakib et al.· SAS Journal of Medicine· 0 citations
The future of AI in radiation oncology is unlikely to be the replacement of the radiation oncologist, but rather a human–AI partnership in which automation supports clinical expertise, and the need to define responsibility when AI-generated outputs are used in patient care is defined.
S. Ichou, K. Nouni, A. Lachgar et al.· MedPeer publisher· 0 citations
Evaluating the association between tumor stage and treatment-related toxicity in patients treated for laryngeal cancer at the National Institute of Oncology in Rabat between January 2022 and January 2024 found no clear link between tumor stage and treatment-related toxicity.
F. Chakib, I. Lahlou, A. Lachgar et al.· SAS Journal of Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.